BILL ANALYSIS

S4799

BEARISH

Slash the Pentagon Act

S4799 (Slash the Pentagon Act) has been assessed with a bearish outlook for investors. The primary sectors impacted are Defense. View the full bill text on Congress.gov.

bearish

Market Sentiment

6/10

Impact Score

Sectors Impacted

Key Takeaways for Investors

S. 4799 would cap FY2027 defense budget at $750B, forcing 16% cut vs current baseline

Exemptions for health and personnel shift cuts entirely onto procurement and R&D accounts

Pure-play contractors (HII, LDOS) face disproportionate revenue risk; diversified primes (LMT, RTX) see more manageable but real headwinds

Bill is in early stage with single sponsor — passage probability low, but signals potential baseline pressure in upcoming NDAA debate

How S4799 Affects the Market

The market has not priced in a $750B defense cap because passage is viewed as remote. However, the bill's introduction frames the FY2027 NDAA debate: baseline growth assumptions may be trimmed, and contractors reliant on large procurement programs (submarines for HII, F-35 for LMT) could see sentiment pressure during appropriations season. Investors should watch NDAA markups for any downward adjustment in topline, which would directly affect revenue visibility for these tickers.

Bill Details

Metric	Value
Bill Number	S4799
Market Sentiment	bearish
Event Date	June 16, 2026
Affected Sectors	Defense
Source	View on Congress.gov →

Summary

Sen. Markey's S. 4799 would cap FY2027 defense budget authority at $750B, imposing a real dollar reduction against projected baseline. The bill is in early legislative stage with single Democratic sponsor and no companion, so passage probability is low. If enacted, it would pressure margins at every major defense prime.

Full AI Market Analysis

On June 16, 2026, Sen. Markey introduced S. 4799, the 'Slash the Pentagon Act,' in the 119th Congress. The bill was read twice and referred to the Committee on Armed Services — a typical early stage for a single-sponsored Democrat bill in a GOP-controlled chamber. The bill's actual text imposes a hard cap of $750 billion on the amount authorized to be appropriated for the national defense budget for fiscal year 2027, with explicit protections for the Defense Health Program and military personnel accounts. This means all other accounts — procurement, R&D, operations and maintenance — would bear the full burden of any reduction below the current baseline. The current FY2026 defense budget is approximately $895 billion; a $750B cap would represent a roughly 16% reduction in top-line authority. The money trail matters: this is an AUTHORIZATION bill, not an appropriation. It sets a ceiling — it does not allocate funds. If enacted, the actual Appropriations Committees would still write spending bills up to that ceiling. However, a legislated cap would preclude any emergency supplement or above-cap baseline growth, forcing real cuts. The protected accounts (health, personnel) are roughly $200B combined, leaving ~$550B for all procurement, R&D, and O&M. Currently, procurement alone is ~$170B, R&D ~$145B. Achieving $750B total would likely require a 25-30% cut in procurement and R&D — dramatic for an industry where many programs are already on multiyear contracts. Structurally, the exposed companies are pure-play defense contractors: HII (shipbuilding, $11.5B rev) and LDOS (services, $15.3B) would be hit hardest proportionate to revenue. LMT, RTX, NOC, GD face larger absolute revenue risk but more diversified revenue bases. BA's defense segment is already loss-making; further cuts would deepen losses. The exemption for personnel and healthcare creates an asymmetric burden on equipment and technology contractors. Legislative timeline: the bill has only a single Democratic sponsor and has not been reported out of committee. In the 119th Congress (2025-2027) with a Republican majority, this bill is extremely unlikely to advance. The more probable market outcome is that it serves as a messaging vehicle for defense spending restraint, potentially influencing the baseline for subsequent negotiations. Near-term investor focus should remain on the actual NDAA markup process in committee, not on this bill.